Xtl Biopharmaceuticals (XTLB) Return on Capital Employed Growth (1y) (2010 - 2024)
Xtl Biopharmaceuticals (XTLB) Return on Capital Employed Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | -3,457.00 |
| 10 | Xtl Biopharmaceuticals | 2.58 Bn | 2.58 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2,116.00 |
| Mar 31, 2022 | -261.00 |
| Dec 31, 2021 | -874.00 |
| Sep 30, 2021 | 3,286.00 |
| Mar 31, 2021 | -835.00 |
| Dec 31, 2020 | 409.00 |
| Sep 30, 2020 | -2,992.00 |
| Jun 30, 2020 | 869.00 |
| Mar 31, 2020 | 607.00 |
| Dec 31, 2019 | -99.00 |
| Sep 30, 2019 | 4,545.00 |
| Jun 30, 2019 | 1,162.00 |
| Mar 31, 2019 | -10.00 |
| Dec 31, 2018 | 924.00 |
| Sep 30, 2018 | -3,765.00 |
| Jun 30, 2018 | -1,603.00 |
| Mar 31, 2018 | 3,552.00 |
| Dec 31, 2017 | 6,042.00 |
| Sep 30, 2017 | 15,368.00 |
| Jun 30, 2017 | 11,888.00 |